ATC Group: L01DB03 Epirubicin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of L01DB03 in the ATC hierarchy

Level Code Title
1 L Antineoplastic and immunomodulating agents
2 L01 Antineoplastic agents
3 L01D Cytotoxic antibiotics and related substances
4 L01DB Anthracyclines and related substances
5 L01DB03 Epirubicin

Active ingredients in L01DB03

Active Ingredient

Epirubicin is a cytotoxic active antibiotic from the anthracycline group. The mechanism of action of epirubicin is related to its ability to bind to DNA. Cell culture studies have shown rapid cell penetration, localisation in the nucleus and inhibition of nucleic acid synthesis and mitosis.

Related product monographs

Document Type Information Source  
 PHARMORUBICIN Solution for injection or infusion MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicines in this ATC group

Australia (AU)

Austria (AT)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

France (FR)

Hong Kong (HK)

Israel (IL)

Lithuania (LT)

Malta (MT)

Mexico (MX)

New Zealand (NZ)

Nigeria (NG)

Poland (PL)

Romania (RO)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.